anidulafungin has been researched along with cancidas in 41 studies
Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (cancidas) | Trials (cancidas) | Recent Studies (post-2010) (cancidas) |
---|---|---|---|---|---|
568 | 33 | 331 | 117 | 1 | 24 |
Protein | Taxonomy | anidulafungin (IC50) | cancidas (IC50) |
---|---|---|---|
1,3-beta-D-glucan synthase catalytic subunit | Candida albicans | 0.0002 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 31 (75.61) | 29.6817 |
2010's | 9 (21.95) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Jacobsen, MD; Odds, FC; Whyte, JA | 1 |
Bocanegra, R; Graybill, JR; Molina, D; Najvar, LK; Olivo, M; Wiederhold, NP | 1 |
Garcia-Effron, G; Hsu, MJ; Kahn, JN; Marr, KA; Park, S; Perlin, DS | 1 |
Balashov, S; Delmas, G; Garcia-Effron, G; Paderu, P; Park, S; Perlin, DS | 1 |
Albert, N; Chamilos, G; Kontoyiannis, DP; Lewis, RE | 1 |
Garcia-Effron, G; Park, S; Perlin, DS; Rocha, EM | 1 |
Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, V; Rex, JH | 1 |
Antachopoulos, C; Meletiadis, J; Roilides, E; Sein, T; Walsh, TJ | 1 |
Chatzimoschou, A; Dalakiouridou, M; Diza-Mataftsi, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Tsantali, C | 1 |
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS | 1 |
Jacobson, MJ; Nguyen, G; Patel, R; Piper, KE; Steckelberg, JM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Edlind, TD; Garcia-Effron, G; Katiyar, SK; Park, S; Perlin, DS | 1 |
Damle, B; Dowell, J; Stogniew, M | 1 |
Chu, CC; Hsueh, PR; Ruan, SY | 1 |
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Lewis, JS; Patterson, TF; Thompson, GR; Vallor, AC; Villareal, NC; Wiederhold, NP | 1 |
Garcia-Effron, G; Grabinski, JL; Lee, SA; Perlin, DS; Wiederhold, NP | 1 |
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
Garcia-Effron, G; Park, S; Perlin, DS | 1 |
Alspaugh, JA; Fortwendel, JR; Juvvadi, PR; Perfect, BZ; Perfect, JR; Pinchai, N; Steinbach, WJ | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Jacobson, MJ; Patel, R; Piper, KE; Steckelberg, JM; Steckelberg, KE | 1 |
Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A | 1 |
Cleary, JD; Garcia-Effron, G; Lee, S; Park, S; Perlin, DS | 1 |
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
Guarro, J; Mariné, M; Pastor, FJ; Pontón, J; Quindós, G; Sahand, IH | 1 |
Canton, E; Espinel-Ingroff, A; Martín-Mazuelo, E; Peman, J | 1 |
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
Cantón, E; del Castillo, L; Espinel-Ingroff, A; Pemán, J | 1 |
Bonilla, H; Chua, DJ; DiPersio, J; Garcia-Effron, G; Ghannoum, M; Perlin, DS; Tomada, JR | 1 |
Bakker-Woudenberg, IA; Fahal, AH; van Belkum, A; van de Sande, WW | 1 |
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN | 1 |
Andes, D; Bohrmuller, J; Diekema, DJ; Lepak, A; Marchillo, K; Pfaller, MA | 1 |
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Liu, W; Wang, S; Yuan, L | 1 |
2 review(s) available for anidulafungin and cancidas
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
Topics: Antifungal Agents; Cell Wall; Drug Discovery; Fungi; GPI-Linked Proteins; Humans; Mannans; Mycoses; Triterpenes | 2020 |
39 other study(ies) available for anidulafungin and cancidas
Article | Year |
---|---|
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic | 2007 |
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peptides, Cyclic; Serum | 2007 |
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
Topics: Amino Acid Sequence; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Protein Subunits | 2007 |
Serum differentially alters the antifungal properties of echinocandin drugs.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides, Cyclic; Serum | 2007 |
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fungemia; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Species Specificity | 2007 |
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.
Topics: Amino Acid Sequence; Amino Acid Substitution; Aspergillus fumigatus; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Molecular Sequence Data; Proline; Sequence Homology, Amino Acid; Serine | 2007 |
Effects of serum on in vitro susceptibility testing of echinocandins.
Topics: Anidulafungin; Aspergillus; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Protein Binding; Serum | 2007 |
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Spores, Fungal | 2008 |
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.
Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candida albicans; Echinocandins; Humans; Microbial Sensitivity Tests | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation | 2008 |
In vitro activity of anidulafungin against Candida albicans biofilms.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Enzyme Inhibitors; Fungal Proteins; Gene Expression; Genes, Fungal; Glucosyltransferases; Humans; Membrane Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Species Specificity | 2008 |
Pharmacokinetics and tissue distribution of anidulafungin in rats.
Topics: Anidulafungin; Animals; Antifungal Agents; Autoradiography; Candidiasis; Carbon Radioisotopes; Echinocandins; Humans; Infusions, Intravenous; Kidney; Liver; Lung; Male; Rats; Rats, Inbred F344; Spleen; Tissue Distribution | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Topics: Adult; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Caspofungin; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides | 2008 |
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Topics: Anidulafungin; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; DNA Mutational Analysis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Point Mutation | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
Topics: Anidulafungin; Candida albicans; Caspofungin; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests | 2009 |
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus.
Topics: Aminoglycosides; Antifungal Agents; Aspergillus fumigatus; beta-Glucans; Calcineurin; Caspofungin; Cell Wall; Chitin; Echinocandins; Fluorescent Dyes; Fungal Proteins; Genes, Fungal; Genes, ras; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Mutation; Signal Transduction | 2009 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
In vitro activity of micafungin against planktonic and sessile Candida albicans isolates.
Topics: Antifungal Agents; Biofilms; Candida albicans; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton | 2009 |
In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.
Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests | 2009 |
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
Topics: Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Male; Micafungin; Mice | 2009 |
Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Reference Standards | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.
Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microbiological Techniques; Time Factors | 2010 |
Novel FKS mutations associated with echinocandin resistance in Candida species.
Topics: Adult; Antifungal Agents; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Glucosyltransferases; Humans; Male; Middle Aged; Mutation | 2010 |
Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Madurella; Micafungin; Microbial Sensitivity Tests; Mycetoma | 2010 |
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candida albicans; Candida glabrata; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid; Species Specificity | 2010 |
In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Female; Kidney; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding; Species Specificity | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |